×
Health Catalyst EBITDA 2018-2025 | HCAT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Health Catalyst ebitda from 2018 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Health Catalyst EBITDA 2018-2025 | HCAT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Health Catalyst ebitda from 2018 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$45.2B
Doximity (DOCS)
$11.6B
Hims & Hers Health (HIMS)
$11.2B
Tempus AI (TEM)
$10.5B
IRhythm Technologies (IRTC)
$4.3B
Inspire Medical Systems (INSP)
$3.8B
Hinge Health (HNGE)
$3.6B
Privia Health (PRVA)
$2.5B
Enovis (ENOV)
$1.8B
Schrodinger (SDGR)
$1.6B
Phreesia (PHR)
$1.5B
10x Genomics (TXG)
$1.5B
Clover Health Investments (CLOV)
$1.5B
Azenta (AZTA)
$1.5B
Evolent Health (EVH)
$1.3B
Omnicell (OMCL)
$1.3B
Claritev (CTEV)
$733M
Fulgent Genetics (FLGT)
$552M
Veradigm (MDRX)
$531M
Standard BioTools (LAB)
$475M
Butterfly Network (BFLY)
$457M
Talkspace (TALK)
$422M
TruBridge (TBRG)
$328M
Outset Medical (OM)
$312M
Nyxoah SA (NYXH)
$282M
SOPHiA GENETICS SA (SOPH)
$250M
CapsoVision (CV)
$218M
Zepp Health (ZEPP)
$206M
KORU Medical Systems (KRMD)
$152M
American Well (AMWL)
$126M